心血管康复医学杂志2024,Vol.33Issue(2) :248-252.DOI:10.3969/j.issn.1008-0074.2024.02.28

心肌纤维化在左心室舒张功能不全中的作用及其作为治疗靶点的潜力

Role of myocardial fibrosis in left ventricular diastolic dysfunction and its potential as a therapeutic target

缪丽珠 高一群 张树龙
心血管康复医学杂志2024,Vol.33Issue(2) :248-252.DOI:10.3969/j.issn.1008-0074.2024.02.28

心肌纤维化在左心室舒张功能不全中的作用及其作为治疗靶点的潜力

Role of myocardial fibrosis in left ventricular diastolic dysfunction and its potential as a therapeutic target

缪丽珠 1高一群 1张树龙1
扫码查看

作者信息

  • 1. 大连大学附属中山医院心脏中心,辽宁大连 116001
  • 折叠

摘要

心肌纤维化(Myocardial fibrosis,MF)是由缺血、缺氧等因素导致的心肌结构和功能改变,是多种心脏疾病进展过程中的重要病理变化.左心室舒张功能不全(Left ventricular diastolic dysfunction,LVDD)是多种复杂病理变化过程的综合结果,最终进展为射血分数保留型心力衰竭(HFpEF),严重影响患者生活质量及寿命.本文就MF在LVDD过程中的作用作一综述,并讨论目前的治疗研究进展.

Abstract

Myocardial fibrosis(MF)is an important pathological change in the progression of a variety of heart dis-eases due to myocardial structural and functional changes caused by factors such as ischemia and hypoxia.Left ven-tricular diastolic dysfunction(LVDD)is a comprehensive result of a variety of complex pathological processes,which eventually progresses to heart failure with preserved ejection fraction(HFpEF),seriously affecting the quality of life and lifetime of patients.This article reviews the role of MF in the process of LVDD,and discusses the cur-rent research progress of treatment.

关键词

心内膜心肌纤维化症/心室功能障碍,左/治疗

Key words

Endomyocardial fibrosis/Ventricular dysfunction,left/Therapy

引用本文复制引用

出版年

2024
心血管康复医学杂志
福建省康复医学会 中国康复医学会

心血管康复医学杂志

CSTPCD
影响因子:1.157
ISSN:1008-0074
参考文献量35
段落导航相关论文